Details of the Drug

General Information of Drug (ID: DM4PTR3)

Drug Name
N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide
Synonyms CHEMBL563527; N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide; SCHEMBL4619635
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 330.4
Logarithm of the Partition Coefficient (xlogp) 3.8
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C22H22N2O
IUPAC Name
N-(3,3-diphenylpropyl)-2-pyridin-3-ylacetamide
Canonical SMILES
C1=CC=C(C=C1)C(CCNC(=O)CC2=CN=CC=C2)C3=CC=CC=C3
InChI
InChI=1S/C22H22N2O/c25-22(16-18-8-7-14-23-17-18)24-15-13-21(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-12,14,17,21H,13,15-16H2,(H,24,25)
InChIKey
FNEXDTNOFQXKRJ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
11976254
TTD ID
D07BQN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Soluble epoxide hydrolase (EPHX2) TT7WVHI HYES_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Soluble epoxide hydrolase (EPHX2) DTT EPHX2 8.78E-01 -0.1 -0.27
Soluble epoxide hydrolase (EPHX2) DTT EPHX2 4.40E-02 -0.18 -0.42
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem. 2009 Oct 8;52(19):5880-95.